Department of Veterinary Disease Biology, Faculty of Life Sciences, University of Copenhagen is offering a PhD project commencing 1/1 2011 or soon thereafter. The application deadline is December 1st 2010.
The Faculty of Life Science and Novo Nordisk A/S have recently established a research centre - The Novo Nordisk-LIFE In Vivo Pharmacology Centre (NNLIVPC) - with a total budget of DKK 68 mill covering activities until end 2018. The present positions are part of the new Centre´s activities. The purpose of the research centre is to strengthen the research in experimental pharmacology and toxicology and to increase the output of candidates and PhDs with a strong in vivo pharmacological profile. It is expected that the future PhD fellows will be enrolled in the In Vivo Pharmacology PhD program at LIFE and participate actively in this network. The In Vivo Pharmacology PhD program was established in 2006 as a collaboration between the Faculties of Life Sciences, Pharmaceutical Sciences and Health Sciences at the University of Copenhagen, University of Aarhus, and industrial partners; Novo Nordisk A/S, LEO Pharma and H. Lundbeck A/S.
Obesity, increased visceral fat mass, and liver steatosis (fat in liver) are factors associated with increased risk of developing cardiovascular disease. A common side effect following insulin therapy is weight gain - an issue for patients with type 2 diabetes as they often are obese when starting on insulin therapy. At present, the association between insulin-induced weight gain in type 2 diabetic individuals and the risk of developing cardiovascular disease is unclear.
With this project we wish to i) establish how insulin-induced obesity is associated with visceral fat mass and liver steatosis in an animal model of type 2 diabetes, ii) investigate how such changes are associated with relevant blood and tissue markers of inflammation and cardiovascular disease, and iii) investigate how insulin-induced weight gain in patients with type 2 diabetes is associated with changes in markers of cardiovascular disease.Contact:
Professor Jens Lykkesfeldt
Direct Phone: (+45) 35333163
Phd Studentship Unravelling The Molecular Mechanism Of Connective Tissue Growth Factor (Ccn2), University of Liverpool, United Kingdom, 5 days ago
Unravelling the molecular mechanism of connective tissue growth factor (CCN2) in glaucoma Supervisor(s): Professor Colin E. Willoughby & Professor George Bou-Gharios Project description Primary op...
Ph D Student, Ghent University, Netherlands, 5 days ago
Job description A position is available at the Department of Public Health for a highly motivated PhD student to work in an international research project. This is a full-time position for 4 years...
Ph D Fellowship In Molecular Pharmacology, University of Copenhagen, Denmark, 18 days ago
The Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen is pleased to announce that a PhD fellowship will be available from 1 October 2016 ...
Ph D Fellow In Pharmacology, University of Copenhagen, Denmark, 4 days ago
Department of Drug Design and Pharmacology Faculty of Health and Medical Sciences (SUND) University of Copenhagen Department of Drug Design and Pharmacology is offering a three-year PhD fellowship...
Ph D Molecular Genetics, University Medical Center Groningen (UMCG), Netherlands, 7 days ago
Job posted by AcademicTransfer (24/05/2016 03.30) Marie Curie Actions. More 'HR Excellence in Research' logo awarded to institutions actively implementing the European Charter and Code for Researc...
Ph D Scholarship In Synthetic Chemistry And Nanotechnology, Technical University of Denmark, Denmark, 5 days ago
Apply no later than 10 July 2016 Apply for the job at DTU Nanotech by completing the following form. Apply online A PhD position is available for the synthesis and development of polymeric nanomed...